Gemcitabine-associated thrombotic microangiopathy - a role for eculizumab?
Gemcitabine-associated thrombotic microangiopathy (gTMA) is a rare entity that is usually associated with a poor prognosis, with loss of kidney function and often death. The management of this syndrome includes discontinuation of the drug. Other approaches have been tried, with no proven efficacy an...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , , |
| Formato: | report |
| Idioma: | eng |
| Publicado em: |
2019
|
| Assuntos: | |
| Texto completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692019000400012 |
| País: | Portugal |
| Oai: | oai:scielo:S0872-01692019000400012 |